# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-022440
Filing Date
2024-04-26
Accepted
2024-04-26 16:08:35
Documents
21
Period of Report
2024-06-05

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | ny20022201x1_def14a.htm iXBRL | DEF 14A | 1814421
6 |  | logo_nektar.jpg | GRAPHIC | 14135
7 |  | ny20022201x1_barchart01.jpg | GRAPHIC | 176572
8 |  | ny20022201x1_pvp01.jpg | GRAPHIC | 159363
9 |  | ny20022201x1_pvp02.jpg | GRAPHIC | 157736
10 |  | ny20022201x1_pvp03.jpg | GRAPHIC | 164233
11 |  | ny20022201x1-pc_1.jpg | GRAPHIC | 605328
12 |  | ny20022201x1-pc_2.jpg | GRAPHIC | 595658
| Complete submission text file | 0001140361-24-022440.txt |  | 7450191

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | INLINE XBRL TAXONOMY EXTENSION - SCHEMA | nktr-20240605.xsd | EX-101.SCH | 4805
3 | INLINE XBRL TAXONOMY EXTENSION - DEFINITION LINKBASE | nktr-20240605_def.xml | EX-101.DEF | 5397
4 | INLINE XBRL TAXONOMY EXTENSION - LABEL LINKBASE | nktr-20240605_lab.xml | EX-101.LAB | 10154
5 | INLINE XBRL TAXONOMY EXTENSION - PRESENTATION LINKBASE | nktr-20240605_pre.xml | EX-101.PRE | 4703
24 | EXTRACTED XBRL INSTANCE DOCUMENT | ny20022201x1_def14a_htm.xml | XML | 215761

Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-24006 | Film No.: 24883700
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)